RMD - ResMed Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
3,763,275
3,578,127
3,196,825
2,957,013
2,606,572
Cost of revenue
1,629,048
1,553,816
1,357,725
1,239,227
1,069,987
Gross profit
2,134,227
2,024,311
1,839,100
1,717,786
1,536,585
Operating expenses
Research development
264,180
253,575
225,284
201,946
180,651
Selling general and administrative
782,150
739,372
670,387
676,689
645,010
Total operating expenses
1,079,476
1,024,025
926,749
908,727
900,599
Operating income or loss
1,054,751
1,000,286
912,351
809,059
635,986
Interest expense
-
-
23,989
40,377
36,156
Total other income/expenses net
-26,382
-17,491
-5,062
-36,615
-83,282
Income before tax
999,893
960,483
883,662
733,088
518,847
Income tax expense
190,428
181,046
409,157
111,414
114,255
Income from continuing operations
809,465
779,437
474,505
621,674
404,592
Net income
809,465
779,437
474,505
621,674
404,592
Net income available to common shareholders
809,465
779,437
474,505
621,674
404,592
Basic EPS
-
5.34
3.27
4.31
2.83
Diluted EPS
-
5.30
3.24
4.27
2.80
Basic average shares
-
146,066
145,313
144,338
143,111
Diluted average shares
-
147,043
146,451
145,652
144,484
EBITDA
-
1,194,127
1,103,869
990,432
786,781